United States · FDA National Drug Code directory

levocetirizine dihydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 42543-712_e0dc4ba0-8ea1-47c3-8bed-427969ca5c15
Product NDC: 42543-712
Form: TABLET
Composition / generic term: levocetirizine dihydrochloride
Labeler: Vensun Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20141027
Source listing expiry: 20261231

Source-listed ingredients

LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

300 TABLET in 1 BOTTLE (42543-712-03) · 42543-712-03
30 TABLET in 1 BOTTLE (42543-712-30) · 42543-712-30
90 TABLET in 1 BOTTLE (42543-712-90) · 42543-712-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →